Weight loss injections like Ozempic and Wegovy have taken the health world by storm, with headlines touting everything from rapid weight loss to cancer prevention. But as these medications become increasingly popular for cosmetic and convenience weight loss, it’s crucial to separate genuine medical benefits from widespread misconceptions. We’ve consulted leading experts to address 13 of the most common beliefs surrounding GLP-1 therapies, helping you make informed decisions about this powerful treatment option.
The Hunger Suppression Myth: What GLP-1s Really Do
Many believe these medications completely eliminate hunger. In reality, GLP-1 drugs work by mimicking the natural gut hormone glucagon-like peptide-1, which plays a role in appetite regulation. Dr Federica Amati, nutrition lead at Imperial College School of Medicine, explains that while these medications significantly suppress appetite, they don’t banish hunger entirely. “The medicine is about 1,000 times stronger than what we naturally produce from our gut,” she notes. When food passes through the digestive system, L-cells detect nutrients and trigger GLP-1 release. Normally, this natural response lasts mere minutes, but the medications extend this effect dramatically, creating a sustained feeling of fullness that helps many people eat less without eliminating hunger completely.
Managing Side Effects: Preparing Your Body for Treatment
Gastrointestinal symptoms including nausea, constipation, diarrhoea, bloating and vomiting are recognised side effects of GLP-1 medications. Dr Adrian Brown, associate professor and specialist dietitian at University College London, confirms these issues typically emerge during dose escalation but tend to improve over time. Prevention strategies include eating smaller, more frequent meals, maintaining adequate hydration, and limiting fatty foods. Dr Amati emphasizes the importance of preparing your digestive system before starting treatment: “One of the best ways to prevent these side-effects is to prepare your gut, liver and pancreas before you start taking the medications.” She advises increasing plant-based foods and gradually boosting fibre intake prior to beginning therapy. Additionally, she recommends stopping eating immediately when feeling full, as the slow gastric emptying means pushing past satiety only worsens symptoms.
Hydration and Nutrition: The Hidden Challenges
While GLP-1 medications don’t directly suppress thirst, reduced food intake often leads to decreased water consumption. Dr Amati explains that these drugs can reduce overall calorie intake by up to 40%, and many people eat less hydrating fruits and vegetables. “It’s important that you do drink, because dehydration is one of the key reasons why reflux and constipation may be worse,” she warns. Beyond hydration, long-term use can create nutrient deficiencies. Dr Brown’s research reveals some patients may lack sufficient vitamin D, vitamin B12, iron, calcium and protein. Those with already healthy diets generally maintain adequate nutrition while eating less, but individuals with poor dietary habits face genuine malnutrition risks. Professor Giles Yeo from the University of Cambridge stresses that medication alone isn’t sufficient: “You can’t just inject yourself and hope for the best. You have to think about your diet and exercise.”
The Weight Regain Question: Understanding the Long-term Reality
The concern about weight regain after discontinuing GLP-1 therapy reflects a fundamental truth about obesity: it’s a chronic, relapsing condition. Dr Brown explains that when obesity medications stop, the body actively attempts weight restoration, with studies showing people can regain approximately 60% of lost weight. Research from the University of Oxford indicates weight typically returns to baseline within two years of stopping treatment. However, Professor Yeo offers perspective: “For a lot of people, these are likely to be long-term or for ever drugs.” He draws parallels to other chronic condition medications like those for hypertension and cholesterol, suggesting GLP-1s may soon follow similar long-term usage patterns. The key insight is that appetite suppression only occurs during active treatment—discontinuation means returning to pre-treatment hunger levels and weight regulation mechanisms.
Why it Matters
Understanding the actual effects and limitations of GLP-1 medications is essential as they transition from niche diabetes treatments to mainstream weight management tools. With increasing accessibility comes the risk of inappropriate use for purely aesthetic reasons, potentially leading to unhealthy body composition changes and nutritional deficiencies. As researchers continue uncovering additional benefits like potential cancer risk reduction and cardiovascular protection, proper medical guidance becomes even more critical. Patients must approach these powerful medications with realistic expectations, understanding they’re not quick fixes but rather sophisticated interventions requiring comprehensive lifestyle support and potentially lifelong commitment for sustainable results.
